CellProthera, a clinical-stage biotechnology company developing regenerative cell therapies for ischemic diseases, today announced the appointment of Jérôme Hirtzlin and Anne de la Fortelle to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results